Inaccuracy of routine susceptibility tests for detection of erythromycin resistance of Campylobacter jejuni and Campylobacter coli

Clinical Microbiology and Infection

Volumn 16, Issue 1, 2010, Pages 51-56

  van der Beek, M T ^a   Claas, E C J ^a   Mevius, D J ^b,c   van Pelt, W ^d   Wagenaar, J A ^b,c,e   Kuijper, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

23S rRNA gene; Campylobacter coli; Campylobacter jejuni; Erythromycin resistance; Susceptibility testing

Indexed keywords

ERYTHROMYCIN; RNA 23S;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATE; BROTH DILUTION; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISK DIFFUSION; GENE SEQUENCE; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI;

EID: 71849120410     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02755.x     Document Type: Article

References (38)

1. Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL. Human campylobacteriosis in developing countries. Emerg Infect Dis 2002, 8:237-244.
2. Samuel MC, Vugia DJ, Shallow S, Marcus R, Segler S, McGivern T. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis 2004, 15(suppl 3):165-174.
3. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001, 15:1201-1206.
4. van Pelt W, Wannet WJB, van Giessen AW, Mevius DJ, Koopmans MPG, van Duynhoven YTHP. Trends in gastroenteritis 1996-2004. Infectieziekten Bull 2005, 7:250-256.
5. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 2001, 7:24-34.
6. Salazar-Lindo E, Sack RB, Chea-Woo E. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr 1986, 109:355-360.
7. Gibreel A, Kos VN, Keelan M. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother 2005, 49:2753-2759.
8. Kurincic M, Botteldoorn N, Herman L, Smole MS. Mechanisms of erythromycin resistance of Campylobacter spp. isolated from food, animals and humans. Int J Food Microbiol 2007, 120:186-190.
9. Payot S, Bolla JM, Corcoran D, Fanning S, Megraud F, Zhang Q. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect 2006, 8:1967-1971.
10. Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 2006, 58:243-255.
11. Helms M, Simonsen J, Olsen KE, Molbak K. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J Infect Dis 2005, 1:1050-1055.
12. van Pelt W, Wannet WJB, van Giessen AW, Mevius DJ, van Duynhoven YTHP. Trends in gastroenteritis in the Netherlands, 1996-2003. Infectieziekten Bull 2004, 15:335-341.
13. van Hees BC, Veldman-Ariesen MJ, de Jongh BM, Tersmette M, van Pelt W. Regional and seasonal differences in incidence and antibiotic resistance of Campylobacter from a nationwide surveillance study in the Netherlands: an overview of 2000-2004. Clin Microbiol Infect 2007, 13:305-310.
14. Doorduyn Y, van den Brandhof WE, van Duynhoven YTHP, Wagenaar JA, van Pelt W. Risk factors for endemic Campylobacter jejuni infections in the Netherlands: a case control study 2004, Proceedings of the 5th World Congress of Foodborne Infections and Intoxications, Berlin
15. Doorduyn Y, van den Brandhof WE, van Duynhoven YT, Wannet WJ, van Pelt W. Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in the Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect 2006, 134:617-626.
16. Fermer C, Engvall EO. Specific PCR identification and differentiation of the thermophilic Campylobacters, Campylobacter jejuni, C. coli, C. lari, and C. upsaliensis. J Clin Microbiol 1999, 37:3370-3373.
17. Marshall SM, Melito PL, Woodward DL, Johnson WM, Rodgers FG, Mulvey MR. Rapid identification of Campylobacter, Arcobacter, and Helicobacter isolates by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene. J Clin Microbiol 1999, 37:4158-4160.
18. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria: Approved Guideline. 2006, CLSI document M45-A, Pennsylvania, CLSI
19. Kuijper EJ, Stevens S, Imamura T, De Wever B, Claas EC. Genotypic identification of erythromycin-resistant Campylobacter isolates as helicobacter species and analysis of resistance mechanism. J Clin Microbiol 2003, 41:3732-3736.
20. Gaudreau C, Gilbert H. Comparison of disk diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J Antimicrob Chemother 1997, 39:707-712.
21. Luangtongkum T, Morishita TY, El-Tayeb AB, Ison AJ, Zhang Q. Comparison of antimicrobial susceptibility testing of Campylobacter spp. by the agar dilution and the agar disk diffusion methods. J Clin Microbiol 2007, 45:590-594.
22. McDermott PF, Bodeis SM, Aarestrup FM, Brown S, Traczewski M, Fedorka-Cray P. Development of a standardized susceptibility test for Campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb Drug Resist 2004, 10:124-131.
23. King A. Recommendations for susceptibility tests on fastidious organisms and those requiring special handling. J Antimicrob Chemother 2001, 48(suppl 1):77-80.
24. Hakanen A, Huovinen P, Kotilainen P, Siitonen A, Jousimies-Somer H. Quality control strains used in susceptibility testing of Campylobacter spp. J Clin Microbiol 2002, 40:2705-2706.
25. Baker CN. The E-test and Campylobacter jejuni. Diagn Microbiol Infect Dis 1992, 15:469-472.
26. Fernandez H, Mansilla M, Gonzalez V. Antimicrobial susceptibility of Campylobacter jejuni subsp. jejuni assessed by E-test and double dilution agar method in Southern Chile. Mem Inst Oswaldo Cruz 2000, 95:247-249.
27. Huang MB, Baker CN, Banerjee S, Tenover FC. Accuracy of the E-test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J Clin Microbiol 1992, 30:3243-3248.
28. Luber P, Bartelt E, Genschow E, Wagner J, Hahn H. Comparison of broth microdilution, E-test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. J Clin Microbiol 2003, 41:1062-1068.
29. Alarcon T, Domingo D, Prieto N, Lopez-Brea M. Clarithromycin resistance stability in Helicobacter pylori: influence of the MIC and type of mutation in the 23S rRNA. J Antimicrob Chemother 2000, 46:613-616.
30. Hulten K, Gibreel A, Skold O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 1997, 41:2550-2553.
31. Xia HX, Buckley M, Keane CT, O'Morain CA. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother 1996, 37:473-481.
32. Mamelli L, Amoros JP, Pages JM, Bolla JM. A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int J Antimicrob Agents 2003, 22:237-241.
33. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995, 39:577-585.
34. Vacher S, Menard A, Bernard E, Santos A, Megraud F. Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR. Microb Drug Resist 2005, 11:40-47.
35. Booka M, Okuda M, Shin K. Polymerase chain reaction-restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample. Helicobacter 2005, 10:205-213.
36. Megraud F. Basis for the management of drug-resistant Helicobacter pylori infection. Drugs 2004, 64:1893-1904.
37. Schabereiter-Gurtner C, Hirschl AM, Dragosics B. Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J Clin Microbiol 2004, 42:4512-4518.
38. Vacher S, Menard A, Bernard E, Megraud F. PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. Antimicrob Agents Chemother 2003, 47:1125-1128.